UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA

Neurobiology of disease, 2011-06, Vol.42 (3), p.391-403

2011

Volltextzugriff (PDF)

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

Pharmacological reviews, 2003-09, Vol.55 (3), p.463-508

2003

Volltextzugriff (PDF)

Selective Vulnerability in Striosomes and in the Nigrostriatal Dopaminergic Pathway After Methamphetamine Administration

Neurotoxicity research, 2010-07, Vol.18 (1), p.48-58

2010

Volltextzugriff (PDF)

Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders

Psychopharmacology, 2013-11, Vol.230 (1), p.125-135

2013

Volltextzugriff (PDF)

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

Psychopharmacology, 2004-05, Vol.173 (3-4), p.249-263

2004

Volltextzugriff (PDF)

Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice

Journal of neurochemistry, 2008-11, Vol.107 (4), p.1102-1112

2008

Volltextzugriff (PDF)

A Study on the Mechanisms by Which Minocycline Protects Against MDMA (‘Ecstasy’)-Induced Neurotoxicity of 5-HT Cortical Neurons

Neurotoxicity research, 2010-08, Vol.18 (2), p.187-199

2010

Volltextzugriff (PDF)

A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain

British journal of pharmacology, 2001-12, Vol.134 (8), p.1711-1723

2001

Volltextzugriff (PDF)

Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine

Neuropharmacology, 2014-12, Vol.87, p.125-134

2014

Volltextzugriff (PDF)

Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") exhibit increased ethanol consumption and preference

The Journal of pharmacology and experimental therapeutics, 2007-09, Vol.322 (3), p.1003-1012

2007

Volltextzugriff (PDF)

Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4‐methylenedioxymethamphetamine (‘ecstasy’)‐induced dopamine release and free radical formation in the mouse striatum

Journal of neurochemistry, 2002-06, Vol.81 (5), p.961-972

2002

Volltextzugriff (PDF)

Selective Vulnerability in Striosomes and in the Nigrostriatal Dopaminergic Pathway After Methamphetamine Administration: Early Loss of TH in Striosomes After Methamphetamine

Neurotoxicity research, 2010-07, Vol.18 (1), p.48-58

2010

Volltextzugriff (PDF)

Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke

The FASEB journal, 2003-11, Vol.17 (14), p.1-17

2003

Volltextzugriff (PDF)

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

European journal of pharmacology, 2004-10, Vol.500 (1), p.3-13

2004

Volltextzugriff (PDF)

Is frequent dosing with ecstasy a risky business for dopamine-containing neurons?

Trends in pharmacological sciences (Regular ed.), 2003-06, Vol.24 (6), p.272-274

2003

Volltextzugriff (PDF)

The nNOS inhibitor, AR‐R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum

Journal of neurochemistry, 2003-04, Vol.85 (2), p.515-524

2003

Volltextzugriff (PDF)

The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats

British journal of pharmacology, 2002-01, Vol.135 (1), p.170-180

2002

Volltextzugriff (PDF)

Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain

Psychopharmacology, 2007-01, Vol.189 (4), p.459-470

2007

Volltextzugriff (PDF)

Elevation of Ambient Room Temperature has Differential Effects on MDMA-Induced 5-HT and Dopamine Release in Striatum and Nucleus Accumbens of Rats

Neuropsychopharmacology (New York, N.Y.), 2005-07, Vol.30 (7), p.1312-1323

2005

Volltextzugriff (PDF)

Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre‐treatment against 3,4‐methylenedioxymethamphetamine toxicity in rat brain

Journal of neurochemistry, 2007-06, Vol.101 (5), p.1272-1283

2007

Volltextzugriff (PDF)

Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures

British journal of pharmacology, 2005-09, Vol.146 (2), p.306-312

2005

Volltextzugriff (PDF)

Factors contributing to the enhancement of MDMA-induced 5-HT depletion by ethanol: a reply to Byron and Cassel

Psychopharmacology, 2007-03, Vol.190 (4), p.581-582

2007

Volltextzugriff (PDF)

On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor

Psychopharmacology, 2003-01, Vol.165 (3), p.317-319

2003

Volltextzugriff (PDF)

Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats

Journal of neurochemistry, 2001-10, Vol.79 (2), p.456-459

2001

Volltextzugriff (PDF)

Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones

Journal of psychopharmacology (Oxford), 2004-09, Vol.18 (3), p.412-416

2004

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)

Erscheinungsjahr

n.n

Thema

Animals
(45)
Life Sciences & Biomedicine
(42)
Science & Technology
(42)
Male
(36)
Biological And Medical Sciences
(31)
Medical Sciences
(29)
Neurosciences
(28)
Neurosciences & Neurology
(27)
Pharmacology & Pharmacy
(26)
Rats
(25)
N-Methyl-3,4-Methylenedioxyamphetamine - Toxicity
(20)
Serotonin - Metabolism
(18)
Dopamine - Metabolism
(17)
Neurotoxicity
(17)
Pharmacology. Drug Treatments
(17)
Brain - Metabolism
(16)
Mice
(16)
Dopamine
(15)
Ecstasy
(15)
3,4-Methylenedioxymethamphetamine
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

Selective Vulnerability in Striosomes and in the Nigrostriatal Dopaminergic Pathway After Methamphetamine Administration

Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice

A Study on the Mechanisms by Which Minocycline Protects Against MDMA (‘Ecstasy’)-Induced Neurotoxicity of 5-HT Cortical Neurons

A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain

Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine

Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") exhibit increased ethanol consumption and preference

Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4‐methylenedioxymethamphetamine (‘ecstasy’)‐induced dopamine release and free radical formation in the mouse striatum

Selective Vulnerability in Striosomes and in the Nigrostriatal Dopaminergic Pathway After Methamphetamine Administration: Early Loss of TH in Striosomes After Methamphetamine

Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

Is frequent dosing with ecstasy a risky business for dopamine-containing neurons?

The nNOS inhibitor, AR‐R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum

The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats

Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain

Elevation of Ambient Room Temperature has Differential Effects on MDMA-Induced 5-HT and Dopamine Release in Striatum and Nucleus Accumbens of Rats

Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre‐treatment against 3,4‐methylenedioxymethamphetamine toxicity in rat brain

Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures

Factors contributing to the enhancement of MDMA-induced 5-HT depletion by ethanol: a reply to Byron and Cassel

On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor

Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats

Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones

Suchergebnisse filtern